These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32737202)

  • 1. Modulating disease-relevant tau oligomeric strains by small molecules.
    Lo Cascio F; Garcia S; Montalbano M; Puangmalai N; McAllen S; Pace A; Palumbo Piccionello A; Kayed R
    J Biol Chem; 2020 Oct; 295(44):14807-14825. PubMed ID: 32737202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies.
    Puangmalai N; Bhatt N; Montalbano M; Sengupta U; Gaikwad S; Ventura F; McAllen S; Ellsworth A; Garcia S; Kayed R
    Cell Death Dis; 2020 May; 11(5):314. PubMed ID: 32366836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives.
    Lo Cascio F; Puangmalai N; Ellsworth A; Bucchieri F; Pace A; Palumbo Piccionello A; Kayed R
    Sci Rep; 2019 Dec; 9(1):19011. PubMed ID: 31831807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
    Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
    J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies.
    Lo CH; Lim CK; Ding Z; Wickramasinghe SP; Braun AR; Ashe KH; Rhoades E; Thomas DD; Sachs JN
    Alzheimers Dement; 2019 Nov; 15(11):1489-1502. PubMed ID: 31653529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azure C Targets and Modulates Toxic Tau Oligomers.
    Lo Cascio F; Kayed R
    ACS Chem Neurosci; 2018 Jun; 9(6):1317-1326. PubMed ID: 29378132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies.
    Montalbano M; Majmundar L; Sengupta U; Fung L; Kayed R
    Brain Pathol; 2023 Jan; 33(1):e13112. PubMed ID: 36054524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms and implications for the formation of tau oligomeric strains.
    Gerson JE; Mudher A; Kayed R
    Crit Rev Biochem Mol Biol; 2016; 51(6):482-496. PubMed ID: 27650389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
    Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
    Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies.
    Pasinetti GM; Ksiezak-Reding H; Santa-Maria I; Wang J; Ho L
    J Neurochem; 2010 Sep; 114(6):1557-68. PubMed ID: 20569300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein.
    Nieznanska H; Boyko S; Dec R; Redowicz MJ; Dzwolak W; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166209. PubMed ID: 34246750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau exhibits unique seeding properties in globular glial tauopathy.
    Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
    Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies.
    Rayman JB
    Expert Opin Ther Targets; 2023; 27(4-5):269-279. PubMed ID: 37140480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    Davidowitz EJ; Krishnamurthy PK; Lopez P; Jimenez H; Adrien L; Davies P; Moe JG
    J Alzheimers Dis; 2020; 73(1):147-161. PubMed ID: 31771053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Applications of Stable Tau Oligomers in Cell Biology and Electrophysiology Studies.
    Hill E; Moffat KG; Wall MJ; Zetterberg H; Blennow K; Karikari TK
    Methods Mol Biol; 2023; 2551():147-161. PubMed ID: 36310202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The proceeding of drug development based on the propagation of tau protein].
    Suzuki G; Hasegawa M
    Nihon Rinsho; 2016 Mar; 74(3):432-7. PubMed ID: 27025082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.